Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 91 Pages
Report ld: 3454496
Request Sample
Customized Report
Live Poultry Vaccine Market Size(US$)

CAGR 2025-2031
4.5%
Market Size,2031
USD 2,408
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Live Poultry Vaccine was valued at US$ 1777 million in the year 2024 and is projected to reach a revised size of US$ 2408 million by 2031, growing at a CAGR of 4.5% during the forecast period.
A live poultry vaccine is a type of biological preparation used for preventing avian influenza outbreaks in chicken flocks. It contains attenuated strains of avian influenza virus and works by triggering immune responses against viral antigens present in sick birds without causing disease symptoms or death. Unlike conventional dead virus-based vaccines, live poultry vaccines require refrigerated storage and prompt administration after opening for best efficacy. Administered via drinking water or spray application methods, they typically provide protection lasting up to six months per dose depending on local environmental stressors and target pathogens. Their use represents one component in overall control strategies combatting the spread of bird flu among commercial poultry farms worldwide.
The global live poultry vaccine market continues to experience robust growth due to factors such as increasing consumer preference for healthier meat products and increasing concerns about food safety. Additionally, there is a heightened awareness of animal welfare issues leading to increased pressure on producers to improve living conditions for animals raised for human consumption. Moreover, the COVID-19 crisis and its impact on supply chain disruptions, coupled with ongoing regulatory hurdles faced by large pharmaceutical firms entering into the space have opened new doors for smaller, agile companies to gain traction in this market. As a result, we anticipate continued growth of novel approaches towards vaccination delivery to ensure better biosecurity measures against pathogen risks in industrial settings.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Live Poultry Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Poultry Vaccine.
The Live Poultry Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Live Poultry Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Poultry Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco Animal Health
Phibro Animal Health
Virbac
Hipra
Venkys
Biovet
Ringpu Biology
Ceva Corporate
KM Biologics
Vaxxinova
Japfa Comfeed Indonesia
Nisseiken
Segment by Type
Injectable Vaccine
Spray Vaccine
Segment by Application
Avian Encephalomyelitis
Chicken Anaemia
Egg Drop Syndrome
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Live Poultry Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Live Poultry Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Live Poultry Vaccine Market Overview
1.1 Product Definition
1.2 Live Poultry Vaccine by Type
1.2.1 Global Live Poultry Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injectable Vaccine
1.2.3 Spray Vaccine
1.3 Live Poultry Vaccine by Application
1.3.1 Global Live Poultry Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Avian Encephalomyelitis
1.3.3 Chicken Anaemia
1.3.4 Egg Drop Syndrome
1.3.5 Others
1.4 Global Live Poultry Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live Poultry Vaccine Revenue 2020-2031
1.4.2 Global Live Poultry Vaccine Sales 2020-2031
1.4.3 Global Live Poultry Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Live Poultry Vaccine Market Competition by Manufacturers
2.1 Global Live Poultry Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Live Poultry Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Live Poultry Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Live Poultry Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live Poultry Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live Poultry Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Live Poultry Vaccine, Date of Enter into This Industry
2.8 Global Live Poultry Vaccine Market Competitive Situation and Trends
2.8.1 Global Live Poultry Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live Poultry Vaccine Players Market Share by Revenue
2.8.3 Global Live Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live Poultry Vaccine Market Scenario by Region
3.1 Global Live Poultry Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Live Poultry Vaccine Sales by Region: 2020-2031
3.2.1 Global Live Poultry Vaccine Sales by Region: 2020-2025
3.2.2 Global Live Poultry Vaccine Sales by Region: 2026-2031
3.3 Global Live Poultry Vaccine Revenue by Region: 2020-2031
3.3.1 Global Live Poultry Vaccine Revenue by Region: 2020-2025
3.3.2 Global Live Poultry Vaccine Revenue by Region: 2026-2031
3.4 North America Live Poultry Vaccine Market Facts & Figures by Country
3.4.1 North America Live Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Live Poultry Vaccine Sales by Country (2020-2031)
3.4.3 North America Live Poultry Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Live Poultry Vaccine Market Facts & Figures by Country
3.5.1 Europe Live Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Live Poultry Vaccine Sales by Country (2020-2031)
3.5.3 Europe Live Poultry Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Poultry Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live Poultry Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Live Poultry Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Live Poultry Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Live Poultry Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Live Poultry Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Live Poultry Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Live Poultry Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Poultry Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Live Poultry Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Live Poultry Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Live Poultry Vaccine Sales by Type (2020-2031)
4.1.1 Global Live Poultry Vaccine Sales by Type (2020-2025)
4.1.2 Global Live Poultry Vaccine Sales by Type (2026-2031)
4.1.3 Global Live Poultry Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Live Poultry Vaccine Revenue by Type (2020-2031)
4.2.1 Global Live Poultry Vaccine Revenue by Type (2020-2025)
4.2.2 Global Live Poultry Vaccine Revenue by Type (2026-2031)
4.2.3 Global Live Poultry Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Live Poultry Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Live Poultry Vaccine Sales by Application (2020-2031)
5.1.1 Global Live Poultry Vaccine Sales by Application (2020-2025)
5.1.2 Global Live Poultry Vaccine Sales by Application (2026-2031)
5.1.3 Global Live Poultry Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Live Poultry Vaccine Revenue by Application (2020-2031)
5.2.1 Global Live Poultry Vaccine Revenue by Application (2020-2025)
5.2.2 Global Live Poultry Vaccine Revenue by Application (2026-2031)
5.2.3 Global Live Poultry Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Live Poultry Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Live Poultry Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Animal Health Live Poultry Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Live Poultry Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Elanco Animal Health
6.4.1 Elanco Animal Health Company Information
6.4.2 Elanco Animal Health Description and Business Overview
6.4.3 Elanco Animal Health Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Animal Health Live Poultry Vaccine Product Portfolio
6.4.5 Elanco Animal Health Recent Developments/Updates
6.5 Phibro Animal Health
6.5.1 Phibro Animal Health Company Information
6.5.2 Phibro Animal Health Description and Business Overview
6.5.3 Phibro Animal Health Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Phibro Animal Health Live Poultry Vaccine Product Portfolio
6.5.5 Phibro Animal Health Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Company Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Virbac Live Poultry Vaccine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Hipra
6.7.1 Hipra Company Information
6.7.2 Hipra Description and Business Overview
6.7.3 Hipra Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hipra Live Poultry Vaccine Product Portfolio
6.7.5 Hipra Recent Developments/Updates
6.8 Venkys
6.8.1 Venkys Company Information
6.8.2 Venkys Description and Business Overview
6.8.3 Venkys Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Venkys Live Poultry Vaccine Product Portfolio
6.8.5 Venkys Recent Developments/Updates
6.9 Biovet
6.9.1 Biovet Company Information
6.9.2 Biovet Description and Business Overview
6.9.3 Biovet Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biovet Live Poultry Vaccine Product Portfolio
6.9.5 Biovet Recent Developments/Updates
6.10 Ringpu Biology
6.10.1 Ringpu Biology Company Information
6.10.2 Ringpu Biology Description and Business Overview
6.10.3 Ringpu Biology Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ringpu Biology Live Poultry Vaccine Product Portfolio
6.10.5 Ringpu Biology Recent Developments/Updates
6.11 Ceva Corporate
6.11.1 Ceva Corporate Company Information
6.11.2 Ceva Corporate Description and Business Overview
6.11.3 Ceva Corporate Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ceva Corporate Live Poultry Vaccine Product Portfolio
6.11.5 Ceva Corporate Recent Developments/Updates
6.12 KM Biologics
6.12.1 KM Biologics Company Information
6.12.2 KM Biologics Description and Business Overview
6.12.3 KM Biologics Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 KM Biologics Live Poultry Vaccine Product Portfolio
6.12.5 KM Biologics Recent Developments/Updates
6.13 Vaxxinova
6.13.1 Vaxxinova Company Information
6.13.2 Vaxxinova Description and Business Overview
6.13.3 Vaxxinova Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vaxxinova Live Poultry Vaccine Product Portfolio
6.13.5 Vaxxinova Recent Developments/Updates
6.14 Japfa Comfeed Indonesia
6.14.1 Japfa Comfeed Indonesia Company Information
6.14.2 Japfa Comfeed Indonesia Description and Business Overview
6.14.3 Japfa Comfeed Indonesia Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Japfa Comfeed Indonesia Live Poultry Vaccine Product Portfolio
6.14.5 Japfa Comfeed Indonesia Recent Developments/Updates
6.15 Nisseiken
6.15.1 Nisseiken Company Information
6.15.2 Nisseiken Description and Business Overview
6.15.3 Nisseiken Live Poultry Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Nisseiken Live Poultry Vaccine Product Portfolio
6.15.5 Nisseiken Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Poultry Vaccine Industry Chain Analysis
7.2 Live Poultry Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Poultry Vaccine Production Mode & Process Analysis
7.4 Live Poultry Vaccine Sales and Marketing
7.4.1 Live Poultry Vaccine Sales Channels
7.4.2 Live Poultry Vaccine Distributors
7.5 Live Poultry Vaccine Customer Analysis
8 Live Poultry Vaccine Market Dynamics
8.1 Live Poultry Vaccine Industry Trends
8.2 Live Poultry Vaccine Market Drivers
8.3 Live Poultry Vaccine Market Challenges
8.4 Live Poultry Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Live Poultry Vaccine was estimated to be worth US$ 1777 million in 2024 and is forecast to a readjusted size of US$ 2408 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 116
USD 3950.00
(Single User License)
A live poultry vaccine is a type of biological preparation used for preventing avian influenza outbreaks in chicken flocks. It contains attenuated strains of avian influenza virus and works by triggering immune responses against viral antigens present in sick birds without causing disease symptoms or death. Unlike conventional dead virus-based vaccines, live poultry vaccines require refrigerated storage and prompt administration after opening for best efficacy. Administered via drinking water or spray application methods, they typically provide protection lasting up to six months per dose depending on local environmental stressors and target pathogens. Their use represents one component in overall control strategies combatting the spread of bird flu among commercial poultry farms worldwide.
Published Date: 2024-01-11
Pages: 136
USD 3950.00
(Single User License)
The global market for Live Poultry Vaccine was estimated to be worth US$ 1777 million in 2024 and is forecast to a readjusted size of US$ 2408 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 116
A live poultry vaccine is a type of biological preparation used for preventing avian influenza outbreaks in chicken flocks. It contains attenuated strains of avian influenza virus and works by triggering immune responses against viral antigens present in sick birds without causing disease symptoms or death. Unlike conventional dead virus-based vaccines, live poultry vaccines require refrigerated storage and prompt administration after opening for best efficacy. Administered via drinking water or spray application methods, they typically provide protection lasting up to six months per dose depending on local environmental stressors and target pathogens. Their use represents one component in overall control strategies combatting the spread of bird flu among commercial poultry farms worldwide.
Published: 2024-01-11
Pages: 136
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now